Ahmadi, S., Wu, Y.S., Li, M., Ip, W., Lloyd-Kuzik, A., Di Paola, M., et al. (2019). Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis. Am J Respir Cell Mol Biol 61(6), 755-764. doi: 10.1165/rcmb.2019-0094OC.
Ahmadi, S., Xia, S., Wu, Y.S., Di Paola, M., Kissoon, R., Luk, C., et al. (2018). SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion. Elife 7. doi: 10.7554/eLife.37963.
Bellec, J., Bacchetta, M., Losa, D., Anegon, I., Chanson, M., and Nguyen, T.H. (2015). CFTR inactivation by lentiviral vector-mediated RNA interference and CRISPR-Cas9 genome editing in human airway epithelial cells. Curr Gene Ther 15(5), 447-459.
Castellani, C., Duff, A.J.A., Bell, S.C., Heijerman, H.G.M., Munck, A., Ratjen, F., et al. (2018). ECFS best practice guidelines: the 2018 revision. J Cyst Fibros 17(2), 153-178. doi: 10.1016/j.jcf.2018.02.006.
Coothankandaswamy, V., Cao, S., Xu, Y., Prasad, P.D., Singh, P.K., Reynolds, C.P., et al. (2016). Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer. Br J Pharmacol 173(23), 3292-3306. doi: 10.1111/bph.13616.
Corvol, H., Blackman, S.M., Boelle, P.Y., Gallins, P.J., Pace, R.G., Stonebraker, J.R., et al. (2015). Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun 6, 8382. doi: 10.1038/ncomms9382.
Cutting, G.R. (2015). Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet 16(1), 45-56. doi: 10.1038/nrg3849.
Di Paola, M., Park, A.J., Ahmadi, S., Roach, E.J., Wu, Y.S., Struder-Kypke, M., et al. (2017). SLC6A14 Is a Genetic Modifier of Cystic Fibrosis That Regulates Pseudomonas aeruginosa Attachment to Human Bronchial Epithelial Cells. MBio 8(6). doi: 10.1128/mBio.02073-17.
Gong, J., Wang, F., Xiao, B., Panjwani, N., Lin, F., Keenan, K., et al. (2019). Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci. PLoS Genet 15(2), e1008007. doi: 10.1371/journal.pgen.1008007.
Hibbard, H.A.J., and Reynolds, M.M. (2019). Fluorescent nitric oxide donor for the detection and killing of Pseudomonas aeruginosa. J Mater Chem B 7(12), 2009-2018. doi: 10.1039/c8tb02552e.
Jain-Vakkalagadda, B., Pal, D., Gunda, S., Nashed, Y., Ganapathy, V., and Mitra, A.K. (2004). Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea. Mol Pharm 1(5), 338-346.
Karunakaran, S., Ramachandran, S., Coothankandaswamy, V., Elangovan, S., Babu, E., Periyasamy-Thandavan, S., et al. (2011). SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer. J Biol Chem 286(36), 31830-31838. doi: 10.1074/jbc.M111.229518.
Karunakaran, S., Umapathy, N.S., Thangaraju, M., Hatanaka, T., Itagaki, S., Munn, D.H., et al. (2008). Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy. Biochem J 414(3), 343-355. doi: 10.1042/BJ20080622.
Kaur, H., and Moreau, R. (2019). Role of mTORC1 in intestinal epithelial repair and tumorigenesis. Cell Mol Life Sci 76(13), 2525-2546. doi: 10.1007/s00018-019-03085-6.
Kerem, B., Rommens, J.M., Buchanan, J.A., Markiewicz, D., Cox, T.K., Chakravarti, A., et al. (1989). Identification of the cystic fibrosis gene: genetic analysis. Science 245(4922), 1073-1080. doi: 10.1126/science.2570460.
Kulich, M., Rosenfeld, M., Campbell, J., Kronmal, R., Gibson, R.L., Goss, C.H., et al. (2005). Disease-specific reference equations for lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 172(7), 885-891. doi: 10.1164/rccm.200410-1335OC.
Li, W., Soave, D., Miller, M.R., Keenan, K., Lin, F., Gong, J., et al. (2014). Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities. Hum Genet 133(2), 151-161. doi: 10.1007/s00439-013-1363-7.
Liu, G.Y., and Sabatini, D.M. (2020). mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol 21(4), 183-203. doi: 10.1038/s41580-019-0199-y.
Mao, H., Sheng, J., Jia, J., Wang, C., Zhang, S., Li, H., et al. (2021). Aberrant SLC6A14 Expression Promotes Proliferation and Metastasis of Colorectal Cancer via Enhancing the JAK2/STAT3 Pathway. Onco Targets Ther 14, 379-392. doi: 10.2147/OTT.S288709.
Palazzolo, L., Paravicini, C., Laurenzi, T., Adobati, S., Saporiti, S., Guerrini, U., et al. (2019). SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure. SLAS Discov 24(9), 928-938. doi: 10.1177/2472555219867317.
Pereira, S.V., Ribeiro, J.D., Bertuzzo, C.S., and Marson, F.A.L. (2017). Association of clinical severity of cystic fibrosis with variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1 and SLC9A3). Gene 629, 117-126. doi: 10.1016/j.gene.2017.07.068.
Quanjer, P.H., Stanojevic, S., Cole, T.J., Baur, X., Hall, G.L., Culver, B.H., et al. (2012). Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 40(6), 1324-1343. doi: 10.1183/09031936.00080312.
Raslan, A.A., and Yoon, J.K. (2020). WNT Signaling in Lung Repair and Regeneration. Mol Cells 43(9), 774-783. doi: 10.14348/molcells.2020.0059.
Riordan, J.R., Rommens, J.M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., et al. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245(4922), 1066-1073. doi: 10.1126/science.2475911.
Rommens, J.M., Iannuzzi, M.C., Kerem, B., Drumm, M.L., Melmer, G., Dean, M., et al. (1989). Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245(4922), 1059-1065. doi: 10.1126/science.2772657.
Ruffin, M., Bilodeau, C., Maillé, É., LaFayette, S.L., McKay, G.A., Trinh, N.T., et al. (2016). Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair. Faseb j 30(9), 3011-3025. doi: 10.1096/fj.201500166R.
Ruffin, M., and Brochiero, E. (2019). Repair Process Impairment by Pseudomonas aeruginosa in Epithelial Tissues: Major Features and Potential Therapeutic Avenues. Front Cell Infect Microbiol 9, 182. doi: 10.3389/fcimb.2019.00182.
Ruffin, M., Mercier, J., Calmel, C., Mesinele, J., Bigot, J., Sutanto, E.N., et al. (2020). Update on SLC6A14 in lung and gastrointestinal physiology and physiopathology: focus on cystic fibrosis. Cell Mol Life Sci 77(17), 3311-3323. doi: 10.1007/s00018-020-03487-x.
Shteinberg, M., Haq, I.J., Polineni, D., and Davies, J.C. (2021). Cystic fibrosis. Lancet 397(10290), 2195-2211. doi: 10.1016/S0140-6736(20)32542-3.
Sikder, M.O.F., Sivaprakasam, S., Brown, T.P., Thangaraju, M., Bhutia, Y.D., and Ganapathy, V. (2020). SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling. Biochem J 477(8), 1409-1425. doi: 10.1042/BCJ20200099.
Sikder, M.O.F., Yang, S., Ganapathy, V., and Bhutia, Y.D. (2017). The Na(+)/Cl(-)-Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB(0,+)): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis. AAPS J 20(1), 12. doi: 10.1208/s12248-017-0164-7.
Sivaprakasam, S., Sikder, M.O.F., Ramalingam, L., Kaur, G., Dufour, J.M., Moustaid-Moussa, N., et al. (2021). SLC6A14 deficiency is linked to obesity, fatty liver, and metabolic syndrome but only under conditions of a high-fat diet. Biochim Biophys Acta Mol Basis Dis 1867(5), 166087. doi: 10.1016/j.bbadis.2021.166087.
Sloan, J.L., and Mager, S. (1999). Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+). J Biol Chem 274(34), 23740-23745. doi: 10.1074/jbc.274.34.23740.
Sun, L., Rommens, J.M., Corvol, H., Li, W., Li, X., Chiang, T.A., et al. (2012). Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. 44(5), 562-569. doi: 10.1038/ng.2221.
Valera, F.C.P., Ruffin, M., Adam, D., Maillé, É., Ibrahim, B., Berube, J., et al. (2019). Staphylococcus aureus impairs sinonasal epithelial repair: Effects in patients with chronic rhinosinusitis with nasal polyps and control subjects. J Allergy Clin Immunol 143(2), 591-603.e593. doi: 10.1016/j.jaci.2018.05.035.